logologo
Search anything
arrow
WhatsApp Icon

Zenith Healthcare share price: key facts for 2026

ZENITHHE

Zenith Health Care Ltd

ZENITHHE

Ask AI

Ask AI

Why Zenith Healthcare is in focus

Zenith Healthcare Limited is an integrated pharmaceutical company in India, involved in manufacturing pharmaceutical formulations and offering contract manufacturing across multiple therapeutic areas. With smaller listed companies, investors often look for a quick, factual snapshot that combines price, size, business profile, and key corporate details in one place. The information below brings together the latest share price reference provided, key identifiers such as the BSE symbol, and the company’s registered locations and contacts. It also summarises a past corporate development related to an amalgamation proposal that was disclosed to the BSE.

Stock snapshot as of 7 July 2026

The share price of ZENITHHE as on 7th July 2026 is ₹3.18. This is a single-date reference point and should be read as the price on that day as provided. Alongside price, the market capitalisation listed for the company is ₹20 crore. For investors, these two numbers frame how the market is valuing the stock at that time and the approximate size of the listed entity. The BSE symbol for Zenith Health Care Ltd is 530665, which is useful for tracking filings and corporate updates on exchange platforms.

What the company does

Zenith Healthcare Limited is described as an integrated pharmaceutical company in India. The company manufactures various pharmaceutical formulations and also provides contract manufacturing services. The operations span multiple therapeutic areas, as stated. This positioning typically means the company can serve its own product requirements and also manufacture on behalf of other brands, depending on contract terms and regulatory approvals. The provided details emphasise manufacturing capabilities rather than any specific product brands or distribution footprint.

Product forms and manufacturing lines mentioned

Zenith Health Care Ltd is engaged in manufacturing tablets, capsules, ointments, and liquid injectables, among others. These dosage forms indicate a mix of oral solids, topical products, and sterile or injectable formats (as referenced by “liquid injectable”). The breadth of formats can matter operationally because each category can require different facilities, equipment, and compliance processes. The text does not specify capacity, approvals, or client names, so this summary stays limited to the formats explicitly listed.

Key corporate identifiers and leadership

The parent organisation is listed as Zenith Healthcare Limited. The Managing Director is stated as Shri. Akshit Raycha. The BSE symbol is 530665. These basic identifiers are often used when mapping exchange disclosures to the operating entity, and when verifying management details across filings and corporate communications.

Registered and corporate office details

The company’s registered and corporate office is listed at: 504, Iscon Elegance, Nr. Shapath 5, S.G. Road, Ahmedabad-380015. Another address line is also provided as: 504, Iscon Elegance, Near Ananddham Jain Derasar, Prahladnagar Cross Road, Ahmedabad, Gujarat, Pin Code 380051. The contact emails mentioned are info@zenithhealthcare.com and mahendrazenith@hotmail.com (the latter appears more than once in the provided text). Phone numbers for the office include (079) 66168889 and (079) 66168890, and an additional number 079-66168891 is also listed. Two mobile numbers are mentioned: +91 98250 97076 and +91 94265 16103.

Works location and contact numbers

The works address is given as 388/34, Changodar Ind. Estate, Sarkhej-Bawla Highway, Changodar-382 213, Dist. Ahmedabad. The phone numbers listed for the works are (02717) 250048 and (02717) 250593. The fax number is (02717) 251262. These details help investors and stakeholders locate the manufacturing site reference shared in the text.

Agent information listed in the text

The agent information is provided as: 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri (East), Mumbai 400059, Maharashtra (this address appears repeated). The board number is 022 62638200. The fax number is 022 62638299. The text does not clarify the agent’s scope of work, so it is presented here only as contact information.

Amalgamation proposal disclosure and board meeting (2018)

The text references an application for amalgamation among Zenith Healthcare Limited (ZHL) as the transferee company and Zenith Medicine Pvt. Ltd. (ZMPL) as the transferor company. It also states that ZENITH HEALTH CARE LTD. informed the BSE that a meeting of the Board of Directors was scheduled on 19/10/2018, inter alia, to consider and approve the notice of the 4th Board Meeting (04/2018-19) to be held on 19.10.2018 to consider the proposal for the amalgamation. The content further defines “Approval Date” as the date on which shareholders and regulatory authorities approve the proposed restructuring. No approval date or outcome is provided in the supplied text.

Key facts table

ItemDetail (as provided)
Share price (ZENITHHE)₹3.18 (7 July 2026)
Market capitalisation₹20 crore
BSE symbol530665
Parent organisationZenith Healthcare Limited
Managing DirectorShri. Akshit Raycha
Registered/corporate office504, Iscon Elegance, Nr. Shapath 5, S.G. Road, Ahmedabad-380015
Works388/34, Changodar Ind. Estate, Sarkhej-Bawla Highway, Changodar-382 213, Dist. Ahmedabad
Board meeting (amalgamation proposal)Scheduled on 19/10/2018 (as per BSE intimation in the text)

Tracking corporate actions mentioned

The text suggests tracking mergers and demergers of Zenith Health Care Ltd on the Pocketful platform by visiting the stock page, navigating to Corporate Actions, and selecting the Mergers & Demergers tab. This is presented as a way to view announced, ongoing, or completed restructuring activities. Investors typically also cross-check such information with exchange filings, especially when the reference involves board meetings and restructuring proposals.

Takeaway

Based on the details provided, Zenith Healthcare Limited is a formulations manufacturer with contract manufacturing presence and multiple dosage forms listed, and it was referenced at a share price of ₹3.18 on 7 July 2026 with a ₹20 crore market cap. The company’s key identifiers, addresses, and contact details are clearly listed, along with a historical BSE disclosure about a board meeting scheduled in October 2018 to consider an amalgamation proposal. Any future clarity on restructuring would typically come through formal disclosures and shareholder or regulatory approvals, as implied by the “Approval Date” definition provided.

Frequently Asked Questions

The share price of ZENITHHE as on 7th July 2026 is ₹3.18.
The market capitalisation listed in the provided data is ₹20 crore.
The BSE symbol for Zenith Health Care Ltd is 530665.
The company is engaged in manufacturing tablets, capsules, ointments, and liquid injectables, among other pharmaceutical formulations.
The text mentions an amalgamation application with Zenith Healthcare Limited as transferee and Zenith Medicine Pvt. Ltd. as transferor, and a board meeting scheduled on 19/10/2018 to consider the proposal.

Did your stocks survive the war?

See what broke. See what stood.

Live Q1 Earnings Tracker